Conference Coverage
Conference Coverage
Hypertension worsened by commonly used prescription meds
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
Conference Coverage
A new biomarker of traumatic brain injury?
“Von Willebrand factor may be more specific for acute injuries, given that it does not seem to stay chronically elevated.”
Conference Coverage
Patchy growth of TAVR programs leaves poorer communities behind
Hospitals in metropolitan areas and those serving wealthier patients were more likely to start programs, according to a new cross-sectional...
Conference Coverage
Higher MI shock survival with NCSI protocol: Final results
Final results of the National Cardiogenic Shock Initiative show better survival rates in acute MI shock than seen in previous North American...
Conference Coverage
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...
Conference Coverage
Psoriasis associated with an increased risk of COVID-19 in real-world study
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
Conference Coverage
Half of patients in hospital for COVID-19 get acute kidney injury
It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening...
Conference Coverage
Infective endocarditis from IV drug use tied to hemorrhagic stroke
Conference Coverage
Is there a need for tPA before thrombectomy in patients with stroke?
The MR CLEAN NO IV trial failed to show superiority or noninferiority of direct endovascular treatment over intravenous tPA followed by...
Conference Coverage
Meta-analysis supports late thrombectomy in selected stroke patients
For every 100 patients treated with thrombectomy, 33 will have less disability, and 27 will achieve an independent level of functioning.
Conference Coverage
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
The rationale is to optimize the antibody response to the killed-adenovirus COVID-19 vaccine.